CD8A and neoplasm: Upon pDC vaccination, the authors observed: (1) the migration of injected pDCs as detected by in vivo imaging, (2) a type I IFN signature after each vaccination, (3) CD4 T cell proliferation and antibody production to the FSME antigens, and (4) induction of tumor antigen-specific CD8 T cell responses.